Literature DB >> 6809596

Incidence of Hunter's syndrome.

I D Young, P S Harper.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 6809596     DOI： 10.1007/BF00569230

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  3 in total

1.  Incidence of mucopolysaccharidoses in Israel: is Hunter disease a "Jewish disease"?

Authors:  T Schaap; G Bach
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

2.  The Hunter syndrome in females: is there an autosomal recessive form of iduronate sulfatase deficiency?

Authors:  E F Neufeld; I Liebaers; C J Epstein; S Yatziv; A Milunsky; B R Migeon
Journal:  Am J Hum Genet       Date:  1977-09       Impact factor: 11.025

3.  An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome.

Authors:  I M Archer; P S Harper; F S Wusteman
Journal:  Clin Chim Acta       Date:  1981-04-27       Impact factor: 3.786
  3 in total
  8 in total

1.  An update on the frequency of mucopolysaccharide syndromes in British Columbia.

Authors:  R B Lowry; D A Applegarth; J R Toone; E MacDonald; N Y Thunem
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  For the Sake of Justice: Should We Prioritize Rare Diseases?

Authors:  Niklas Juth
Journal:  Health Care Anal       Date:  2017-03

3.  Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II.

Authors:  Brianna Yund; Kyle Rudser; Alia Ahmed; Victor Kovac; Igor Nestrasil; Julian Raiman; Eva Mamak; Paul Harmatz; Robert Steiner; Heather Lau; Pooja Vekaria; Jeffrey R Wozniak; Kelvin O Lim; Kathleen Delaney; Chester Whitley; Elsa G Shapiro
Journal:  Mol Genet Metab       Date:  2014-12-09       Impact factor: 4.797

4.  Clinical and biochemical studies in mucopolysaccharidosis type II carriers.

Authors:  I V D Schwartz; L L C Pinto; G Breda; L Lima; M G Ribeiro; J G Mota; A X Acosta; P Correia; D D G Horovitz; C G G Porciuncula; E Lipinski-Figueiredo; A C Fett-Conte; R P Oliveira Sobrinho; D Y J Norato; A C Paula; C A Kim; A R Duarte; R Boy; S Leistner-Segal; M G Burin; R Giugliani
Journal:  J Inherit Metab Dis       Date:  2009-10-10       Impact factor: 4.982

Review 5.  Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review.

Authors:  Linda A Bradley; Hamish R M Haddow; Glenn E Palomaki
Journal:  Genet Med       Date:  2017-05-18       Impact factor: 8.822

6.  Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy.

Authors:  Vinicia Assunta Polito; Serena Abbondante; Roman S Polishchuk; Edoardo Nusco; Rosaria Salvia; Maria Pia Cosma
Journal:  Hum Mol Genet       Date:  2010-09-27       Impact factor: 6.150

7.  Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.

Authors:  Latifa Chkioua; Souhir Khedhiri; Salima Ferchichi; Rémy Tcheng; Henda Chahed; Roseline Froissart; Christine Vianey-Saban; Sandrine Laradi; Abdelhedi Miled
Journal:  Diagn Pathol       Date:  2011-05-23       Impact factor: 2.644

8.  Characterization of knee alignment in children with mucopolysaccharidosis types I and II and outcome of treatment with guided growth.

Authors:  Elizabeth Ashby; Deborah Eastwood
Journal:  J Child Orthop       Date:  2015-06-16       Impact factor: 1.548
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.